Agree. Very hopeful. Abbott's regimen is 3 drugs (a protease inhibitor, a polymerase inhibitor, and a NS5A inhibitor all developed by ABT). They had their best results when combining these 3 drugs with Ribavirin, and most effective with GT1b's, but also excellent results for GT1a's, both treatment naives and null responders.
There is no way to know. Some are in Phase 2 trials and some are in Phase 3 trials. After trials are completed, the companies have to compile their data and apply for FDA approval, and then wait to receive approval. After that, it takes time for them to market the drugs before they are actually available to doctors to prescribe. It is a long process.
Copyright 1994-2016MedHelp International.All rights reserved. MedHelp is a division of Aptus Health.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.